paclitaxel has been researched along with Bilirubinemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahra, M; Denecke, T; Jühling, A; Klein, F; Pelzer, U; Riess, H; Roemmler-Zehrer, J; Sinn, M; Striefler, J; Wislocka, L | 1 |
| Al-Batran, SE; Kullmann, F; Kunzmann, V; Oettle, H; Plentz, R; Riess, H; Siveke, J; Springfeld, C; Vogel, A | 1 |
| Buzdar, A; Cohen, PR; Dhingra, K; Gagel, R; Holmes, F; Payne, JY | 1 |
| Argon, A; Aydiner, A; Saip, P; Tas, F; Topuz, E | 1 |
1 review(s) available for paclitaxel and Bilirubinemia
| Article | Year |
|---|---|
Patients with Advanced Pancreatic Cancer and Hyperbilirubinaemia: Review and German Expert Opinion on Treatment with nab-Paclitaxel plus Gemcitabine.
Topics: Albumins; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Evidence-Based Medicine; Expert Testimony; Gemcitabine; Germany; Humans; Hyperbilirubinemia; Paclitaxel; Pancreatic Neoplasms; Treatment Outcome | 2015 |
3 other study(ies) available for paclitaxel and Bilirubinemia
| Article | Year |
|---|---|
Safety and efficacy of Nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer suffering from cholestatic hyperbilirubinaemia-A retrospective analysis.
Topics: Adenocarcinoma; Adult; Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Cholestasis; Databases, Factual; Deoxycytidine; Feasibility Studies; Female; Gemcitabine; Humans; Hyperbilirubinemia; Male; Middle Aged; Paclitaxel; Pancreatic Neoplasms; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2018 |
Paclitaxel: severe mucocutaneous toxicity in a patient with hyperbilirubinemia.
Topics: Anthracyclines; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Eruptions; Erythema Multiforme; Female; Humans; Hyperbilirubinemia; Hypercalcemia; Liver Neoplasms; Middle Aged; Mouth Diseases; Neoplasm Proteins; Paclitaxel; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Proteins; Vaginal Diseases | 1996 |
Safety of paclitaxel in a patient with ovarian cancer and hyperbilirubinemia due to Rotor's syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Hyperbilirubinemia; Hyperbilirubinemia, Hereditary; Middle Aged; Ovarian Neoplasms; Paclitaxel | 2002 |